|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income | |||||
| Interest income | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation (loss) gain, net | |||||
| Unrealized gain on investments, net | |||||
| Comprehensive loss | |||||
| Net loss per share: | |||||
| Basic and diluted (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic and diluted** (in shares) | |||||
Loading...